Received Aug 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 9X254 | IM / RL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | X027903 | SC / LL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y014181 | SC / RL |
12 m.o F Peds pt. presents to Immunizations Clinic, accompanied by Mother, for HEP-A, MMR and Varicella vaccination per Doctor Orders and CDC guidelines. No contraindications were verbalized by the pt's Mother. Dosing schedule and potential side effects were discussed with the pt's Mother who verbalized understanding and had no further questions. Pt. was observed for 15 minutes after administration, with Mother present, per guidelines 10 minutes after vaccine administration it was noted that the Pt. had developed red small blotches only on her face. Clinic from Allergy assessed the patients breathing and heart. Both are at normal rates. No other red small splotches or adverse reaction where found on the rest of her body and limbs. Pt. will continue on with normal routine scheduled vaccines. Clinic dismissed the Pt and her Mother. Pt.'s Mother did not have further questions, or concerns and had no further questions.
No
No
Children's Acetaminophen
NKDA and NKA
N/A